Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

spacer.gif (43 bytes)

FOOD AND DRUG ADMINISTRATION
FOR IMMEDIATE RELEASE

Consumer Media: 888-Info-FDA
January 20, 1999

PRODUCT
Ascription Caplets (aspirin 325 mg), 325 mg, in 100 and 225 caplet bottles; b) Ascriptin Caplets, Maximum Strength (Aspirin 500mg), 500 mg, in 50 and 85 caplet bottles, for the temporary relief of minor aches and pain. Recall #D-094/095-9.

CODE
a) Lot No. 01996, Exp. 3/99, NDC 0067-0147-77, 225 caplets/bottle Lot No. 02719, Exp. 5/99, NDC 0067-0147-68, 100 caplets/bottle Lot No. 23856, Exp. 10/99, NDC 0067-0147-77, 225 caplets/bottle b) Lot No. 02202, Exp. 3/99, NDC 0067-0146-50, 50 caplets/bottle Lot No. 02718, Exp. 3/99, NDC 0067-0146-85, 85 caplets/bottle Lot No. 02698, Exp. 3/99, NDC 0067-0146-85, 85 caplets/bottle.

MANUFACTURER
Novartis Consumer Health, Fort Washington, Pennsylvania.

RECALLED BY
Novartis Consumer Health, Summit, New Jersey, by letter dated December 23, 1998. Firm-initiated recall ongoing.

DISTRIBUTION
Nebraska, Pennsylvania, Georgia, California.

QUANTITY
193,113 units were distributed.

REASON
Dissolution failure.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.